Researchers develop PrecisionView, a handheld AI-powered endomicroscope for real-time, high-resolution cancer diagnostics.
Key Details
- 1PrecisionView combines advanced optics and deep learning to image cellular and vascular structures non-invasively.
- 2Delivers a field of view five times, and depth of field eight times, greater than traditional in vivo microscopy.
- 3Displays real-time images at up to 15 frames per second, enabling clinicians to examine several square centimeters in one scan.
- 4Validated in healthy volunteers and human tissue samples, successfully identifying precancerous and cancerous lesions.
- 5The device is both compact (about the size of a pen) and low-cost (~$3,000), making it suitable for low-resource settings.
- 6Backed by Rice University, MD Anderson Cancer Center, NIH, NCI, and DARPA funding; larger clinical studies pending.
Why It Matters
This technology could significantly improve early cancer detection by making high-resolution microscopy portable, affordable, and usable at the point of care, especially in underserved regions. Integration of AI and hardware design sets a new paradigm for imaging devices in clinical oncology.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.